#treatment

The Food and Drug Administration recently approved a generic formulation of Gilead Sciences’ antiretroviral Truvada.

Continued improvements in ARVs have likely further raised life expectancy for the average 20-year-old who starts treatment today.

GNP+ works with communities of people living with HIV around the world to make sure their voices are heard.

Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.

Researchers have found a new broadly neutralizing antibody against HIV. It is said to be safe, well tolerated and potent.

The National Alliance of State & Territorial AIDS Directors welcomes CDC-funded local jurisdictions. [VIDEO]

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

The country supplies generic meds to much of the world—but thanks to a new law, not for its own citizens living with HIV.

The FDA approved AZT in a record 20 months, a move that remains controversial today.

Find out about all the known risks, benefits, rights and responsibilities.

A commitment to fitness helps insure overall health.

Dispelling misconceptions about conception and HIV

As the HIV population becomes older, an expanding proportion will need treatment for age-related conditions, which will make caring for...

Researchers are in the early stages of developing a USB stick that could measure an HIV-positive person’s viral load.

The HIV reservoir of those on successful treatment for the virus dissipates at a much slower average rate than previously thought, so says..

A survivor and trans women, Sabel Samone-Loreca is an advocates for issues she’s struggled with.